Home Nucleus Medical Devices U.K. Uterine Cancer Diagnostics Market to 2032

U.K. Uterine Cancer Diagnostics Market to 2032

Overview

The U.K. Uterine Cancer Diagnostics Market is expected to reach a 758.47 USD Million by 2032 and is projected to grow at a CAGR of 15.65% from 2025 to 2032.

Revenue, 2024 (USD Million)
335.11
Forecast, 2032 (USD Million)
758.47
CAGR, 2024 - 2032
15.65%
Report Coverage
U.K.

U.K. Uterine Cancer Diagnostics Market 2018-2032 USD Million

U.K. Uterine Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 335.11 USD Million
  • Projected Market Size (2032): 758.47 USD Million
  • CAGR (2025-2032): 15.65%

Key Findings of U.K. Uterine Cancer Diagnostics Market

  • The U.K. Uterine Cancer Diagnostics Market was valued at 335.11 USD Million in 2024.
  • The U.K. Uterine Cancer Diagnostics Market is likely to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Endometrial Cancer in Type Segment accounted for the largest share of the market with a revenue of 1,346.38 USD Million
  • The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 18.91% during the forecast period from 2024 to 2032.

U.K. Uterine Cancer Diagnostics Market Scope

U.K. Uterine Cancer Diagnostics Market Segmentation & Scope
Type
  • Uterine Sarcoma
  • Endometrial Cancer
Diagnostic
  • Procedure Based
  • Instrument-Based
End User
  • Others
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals
Age Group
  • <30 Years
  • 31-40 Years
  • 41-50 Years
  • 51-60 Years
  • >60 Years
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tender

U.K. Uterine Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 335.11 USD Million
Market Value in 2032 758.47 USD Million
CAGR (2025-2032) 15.65%
Historic Data 2016-2023
Market Segments Covered Type,Diagnostic,End User,Age Group,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 335.11 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 335.11 USD Million in 2024.

Segments and Scope

  • U.K. Uterine Cancer Diagnostics Market to 2032, By Type
    • Endometrial Cancer is the largest segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a revenue of 1.35 USD Million in the year 2024.
    • Endometrial Cancer is the Fastest growing segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 15.66 % in forecast period 2025-2032.
  • U.K. Uterine Cancer Diagnostics Market to 2032, By Diagnostic
    • Instrument-Based is the largest segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a revenue of 191.53 USD Million in the year 2024.
    • Instrument-Based is the Fastest growing segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 16.74 % in forecast period 2025-2032.
  • U.K. Uterine Cancer Diagnostics Market to 2032, By End User
    • Hospitals is the largest segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a revenue of 145.65 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 18.91 % in forecast period 2025-2032.
  • U.K. Uterine Cancer Diagnostics Market to 2032, By Age Group
    • >60 Years is the largest segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a revenue of 148.38 USD Million in the year 2024.
    • >60 Years is the Fastest growing segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 17.67 % in forecast period 2025-2032.
  • U.K. Uterine Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a revenue of 153.05 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in U.K. Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 18.62 % in forecast period 2025-2032.

U.K. Uterine Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Medtronic
Koninklijke Philips N.V.
CANON MEDICAL SYSTEMS CORPORATION
General Electric
F. Hoffmann-La Roche Ltd.
U.K. Uterine Cancer Diagnostics Market Company Share Analysis

U.K. Uterine Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Uterine Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Uterine Cancer Diagnostics Market Company Profiling

U.K. Uterine Cancer Diagnostics Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.K. Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,Diagnostic,End User,Age Group,Distribution Channel.
U.K. Uterine Cancer Diagnostics Market was valued at USD 335.11(Revenue in USD Million) in 2021.
U.K. Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
The Endometrial Cancer segment is expected to dominate the U.K. Uterine Cancer Diagnostics Market, holding a largest market share of 1,346.38 USD Million in 2024

U.K. Uterine Cancer Diagnostics Market Scope

U.K. Uterine Cancer Diagnostics Market Segmentation & Scope
Type
  • Uterine Sarcoma
  • Endometrial Cancer
Diagnostic
  • Procedure Based
  • Instrument-Based
End User
  • Others
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Diagnostic Centers
  • Hospitals
Age Group
  • <30 Years
  • 31-40 Years
  • 41-50 Years
  • 51-60 Years
  • >60 Years
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tender
Frequently Asked Questions
The U.K. Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,Diagnostic,End User,Age Group,Distribution Channel.
U.K. Uterine Cancer Diagnostics Market was valued at USD 335.11(Revenue in USD Million) in 2021.
U.K. Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Uterine Cancer Diagnostics Market for final year is USD 758.47 (USD Million).

U.K. Uterine Cancer Diagnostics Market Company Profiling

U.K. Uterine Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The U.K. Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,Diagnostic,End User,Age Group,Distribution Channel.
U.K. Uterine Cancer Diagnostics Market was valued at USD 335.11(Revenue in USD Million) in 2021.
U.K. Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 15.65% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Uterine Cancer Diagnostics Market for final year is USD 758.47 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES